Skip to content
★ Sign in to follow
BT

Brian Tambi

Akorn IncInsys Therapeutics, Inc.
Total declarations
30
Companies
2
▲ Purchases (1 ops.)
€20k
▼ Sales (10 ops.)
€3.2M

Latest filing published 13 May 2019 for AKORN INC.

Filing timeline

BuySale
Brian Tambi

Insider track record

Disclosed buys
1
Disclosed sells
10
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Brian Tambi: trading record in brief

Filings by Brian Tambi span 2 companies, the busiest being Akorn Inc and Insys Therapeutics, Inc. The record holds 30 filings, for trades running from 7 August 2009 to 9 May 2019.

On the open market, the record shows 1 purchase worth €20k and 10 sales worth €3.2M. On balance, insiders were net sellers of €3.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 9 share grants and 10 option exercises.

The record was last updated on 13 May 2019 with a share grant in Akorn Inc. The latest purchase dates back some time: it was published 4,529 days ago, on 16 June 2014. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Brian Tambi

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations30 total
  • ◆
    DirectorExecutivesAkorn Inc
    0SEC
    30,760 shares0Common StockSEC:0001144204-19-025736:0
  • ◆
    DirectorExecutivesInsys Therapeutics, Inc.
    0SEC
    4,000 shares0Common StockSEC:0001209191-18-029966:0
  • ▼
    DirectorExecutivesInsys Therapeutics, Inc.
    1M USD19SEC
    166,504 shares@ US$6.4175.3% of flowCommon StockSEC:0001209191-18-029966:4
  • ◇
    DirectorExecutivesInsys Therapeutics, Inc.
    20,529 USD11SEC
    33,654 shares@ US$0.611.4% of flowCommon StockSEC:0001209191-18-029966:1
  • ◇
    DirectorExecutivesInsys Therapeutics, Inc.
    111,537 USD12SEC
    68,850 shares@ US$1.627.9% of flowCommon StockSEC:0001209191-18-029966:2
  • ◇
    DirectorExecutivesInsys Therapeutics, Inc.
    217,800 USD13SEC
    60,000 shares@ US$3.6315.4% of flowCommon StockSEC:0001209191-18-029966:3
  • ◆
    DirectorExecutivesAkorn Inc
    0SEC
    14,189 shares0Common StockSEC:0001171843-18-002969:0
  • ▼
    DirectorExecutivesAkorn Inc
    503,585 USD14SEC
    15,100 shares@ US$33.3529.2% of flowCommon StockSEC:0001171843-17-007254:0
  • ▼
    DirectorExecutivesAkorn Inc
    172,356 USD24SEC
    5,165 shares@ US$33.379.9% of flowCommon StockSEC:0001171843-17-004905:0
  • ◆
    DirectorExecutivesAkorn Inc
    0SEC
    8,088 shares0Common StockSEC:0001171843-17-002744:0
  • ◆
    DirectorExecutivesAkorn Inc
    0SEC
    4,661 shares0Common StockSEC:0001171843-16-011004:0
  • ◇
    DirectorExecutivesAkorn Inc
    65,250 USD11SEC
    25,000 shares@ US$2.614.0% of flowCommon StockSEC:0001171843-16-010511:0
  • ◇
    DirectorExecutivesAkorn Inc
    165,500 USD12SEC
    25,000 shares@ US$6.6210.1% of flowCommon StockSEC:0001171843-16-010511:1
  • ▼
    DirectorExecutivesAkorn Inc
    768,250 USD31SEC
    25,000 shares@ US$30.7346.9% of flowCommon StockSEC:0001171843-16-010511:2
  • ◇
    DirectorExecutivesInsys Therapeutics, Inc.
    2,196 USD0SEC
    1,800 shares@ US$1.22Common StockSEC:0001209191-15-047221:0
  • ▼
    DirectorExecutivesInsys Therapeutics, Inc.
    108,000 USD0SEC
    1,800 shares@ US$60.00Common StockSEC:0001209191-15-047221:1
  • ◇
    DirectorExecutivesInsys Therapeutics, Inc.
    3,782 USD0SEC
    3,100 shares@ US$1.22Common StockSEC:0001209191-15-047221:2
  • ▼
    DirectorExecutivesInsys Therapeutics, Inc.
    186,279 USD0SEC
    3,100 shares@ US$60.09Common StockSEC:0001209191-15-047221:3
  • ◇
    DirectorExecutivesInsys Therapeutics, Inc.
    1,464 USD0SEC
    1,200 shares@ US$1.22Common StockSEC:0001209191-15-044973:0
  • ▼
    DirectorExecutivesInsys Therapeutics, Inc.
    72,012 USD0SEC
    1,200 shares@ US$60.01Common StockSEC:0001209191-15-044973:1
  • ◇
    DirectorExecutivesInsys Therapeutics, Inc.
    4,758 USD0SEC
    3,900 shares@ US$1.22Common StockSEC:0001209191-15-044973:2
  • ▼
    DirectorExecutivesInsys Therapeutics, Inc.
    234,546 USD0SEC
    3,900 shares@ US$60.14Common StockSEC:0001209191-15-044973:3
  • ▼
    DirectorExecutivesAkorn Inc
    50,232 USD0SEC
    1,200 shares@ US$41.86Common StockSEC:0001171843-14-005923:0
  • ◇
    DirectorExecutivesAkorn Inc
    18,800 USD0SEC
    20,000 shares@ US$0.94Common StockSEC:0001171843-14-004353:0
  • ▼
    DirectorExecutivesAkorn Inc
    524,400 USD0SEC
    13,800 shares@ US$38.00Common StockSEC:0001171843-14-004353:1

25 of 30 declarations